NCT04943705

Brief Summary

This study is designed as a two-dummy randomized controlled trial to evaluate the safety and superiority of Yin and Yang regulating moxibustion in the treatment of menopausal obese patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
216

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 29, 2021

Completed
2 days until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

June 29, 2021

Status Verified

June 1, 2021

Enrollment Period

6 months

First QC Date

June 13, 2021

Last Update Submit

June 27, 2021

Conditions

Keywords

Menopausal ObesityYin and Yang Regulating MoxibustionA Randomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Waist circumference

    The change in waist circumference compared to the baseline.

    Week 0, 4, 8, 12, 18and24.

Secondary Outcomes (11)

  • BMI(weight/height²)

    Week 0, 4, 8, 12, 18and24.

  • Weight(WG)

    Week 0, 4, 8, 12, 18and24.

  • Hip circumference(HC)

    Week 0, 4, 8, 12, 18and24.

  • Waist-to-hip ratio(waist circumference/hip circumference)

    Week 0, 4, 8, 12, 18and24.

  • Body fat percentage(F percent)

    Week 0, 4, 8, 12, 18and24.

  • +6 more secondary outcomes

Study Arms (2)

Yin and Yang Regulating Moxibustion

EXPERIMENTAL

1.The acupoints will be selected as Shenque and Mingmen.The location of the acupoints were based on the national GB/T 12346-2006 acupoints standard.Each treatment was 60min, once a week, Wenyang Yishen moxibustion and Peiyuan Guben moxibustion were performed alternately. Each patient received WenYang Yishen moxibustion and then Peiyuan Guben moxibustion for a total of 12 weeks of treatment and 12 weeks of follow-up at the end of the treatment. 2.The diet and exercise control implementation plan is as follows:Participants weighed ≤113.6 kg (250 lbs) and had a prescription diet of 1200-1499 kcal/day, including traditional foods, of which protein was about 15-20 kcal, fat was about 20-35%, and the rest came from carbohydrates. People weighing ≥113.6 kg are prescribed 1500-1800 kcal per day. They were also instructed to continue moderate-intensity physical activities (such as jogging, brisk walking) at least 5 days a week, at least 210 minutes a week, preferably ≥270 minutes a week。

Device: Yin and Yang Regulating Moxibustion

Mild Moxibustion

ACTIVE COMPARATOR

1.The acupoints will be selected as Zhongwan, Guanyuan, Sanyinjiao (double).The location of the acupoints were based on the national GB/T 12346-2006 acupoints standard.Light one end of the moxa stick and hang it about 2-3cm above the skin, taking the patient's local skin redness and conscious warmth as the degree. Moxa-box moxibustion will be used for 20 minutes each treatment, once every other day, 3 times a week, for a total of 12 weeks of treatment, and 12 weeks of follow-up after the treatment. 2.Lifestyle modification:It will be performed as the same as the Yin and Yang Regulating Moxibustion group.

Device: Yin and Yang Regulating Moxibustion

Interventions

Before making Wenyang Yishen moxibustion, the width and length of the patient's moxibustion site were evaluated by the same body measurement method. Take about 700g of fresh ground ginger with moderate dryness and wetness, and place it on the treatment towel to make a round cake with a diameter of about 20cm and a thickness of about 2.5cm. Spread 25g of moxa moxa with a diameter of about 18cm on top of ginger and light it. When the bottom temperature reaches about 37 degrees, the door can be placed on the patient's waist for treatment. According to the patient's tolerance, the temperature should be controlled at 43-45 degrees. It is better to replace the moxa biscuit every time when the moxa biscuit is burned for about 10 minutes. The patient's local skin has a slight redness and burning. The moxibustion time is 60 minutes. Peiyuan Guben moxibustion is centered on Shenque, and the operation is the same as that of WenYang and Yishen moxibustion.

Mild MoxibustionYin and Yang Regulating Moxibustion

Eligibility Criteria

Age40 Years - 60 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsObesity in female menopause
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients who meet the diagnostic criteria for menopausal syndrome and obesity;
  • Patients with BMI≥25 and waist circumference≥80cm;
  • Female patients between 40-60 years old;
  • Have not taken any hormone drugs or weight loss related drugs in the past 3 months;
  • Sign the informed consent and voluntarily accept the intervention methods of this project.

You may not qualify if:

  • Unexplained vaginal bleeding, or unnatural menopause;
  • Have used hormone replacement therapy or other drugs related to this disease in the past 3 months;
  • Combined with serious organic diseases, endocrine diseases, heart, liver and kidney, and respiratory diseases;
  • Secondary obesity caused by hypothalamic lesions, hypothyroidism, glucocorticoid therapy, etc.;
  • Combined with organic uterine diseases, such as polycystic ovary syndrome, malignant tumors, severe cervical erosion, after total hysterectomy, etc.;
  • There are contraindications to moxibustion, such as moxibustion intolerance, skin allergies, scars, and other serious skin diseases;
  • Poor compliance and unable to adhere to treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hubei Provincial Hospital of Traditional Chinese Medicine

Wuhan, Hubei, 430061, China

Location

Zhong-Yu Zhou

Hubei, China

Location

Related Publications (1)

  • Yu B, Huang W, Zhang Y, Wang J, Xia C, Zhang Y, Xia H, Hu Y, Rao Y, Zhou Z. Efficacy and Safety of Moxibustion for Menopausal Obesity: A Multicentre, Randomized, Controlled Trial Protocol. Evid Based Complement Alternat Med. 2022 Aug 4;2022:9255017. doi: 10.1155/2022/9255017. eCollection 2022.

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Zhong-Yu Zhou, professor

    Hubei Hospital of Traditional Chinese Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zhong-Yu Zhou, professor

CONTACT

Wei Huang, professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2021

First Posted

June 29, 2021

Study Start

July 1, 2021

Primary Completion

December 30, 2021

Study Completion

December 30, 2022

Last Updated

June 29, 2021

Record last verified: 2021-06

Locations